Conventional radiation therapy takes 30‑40 sessions over 6‑8 weeks. Stereotactic body radiation therapy (SBRT) takes 1‑5 sessions. The medical linear accelerator market forecast shows that SBRT is the fastest‑growing application, with a CAGR above 6%. Why the shift? Because patients want shorter treatment, and SBRT is as effective for early‑stage lung, liver, and spine tumours.

What's the catch? SBRT requires a LINAC with image guidance (IGRT) and motion management. The medical linear accelerator market analysis notes that the fastest‑growing end‑user segment is cancer centers, which specialise in advanced techniques like SBRT.

But not every patient is a candidate. SBRT is for small, well‑defined tumours. Large or diffuse tumours still need conventional fractionation.

The bottom line: if you have early‑stage lung or liver cancer, ask about SBRT. It's convenient, effective, and often covered by insurance.